Login / Signup
Hyungjun Youn
ORCID
Publication Activity (10 Years)
Years Active: 2022-2022
Publications (10 Years): 5
Top Topics
Cell Death
Dna Damage Response
Magnetic Nanoparticles
Regulatory T Cells
Top Venues
Bioconjugate chemistry
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Jihoon Jo
,
Sangmin Bae
,
Jinseong Jeon
,
Hyungjun Youn
,
Gyeongjin Lee
,
Changill Ban
Bifunctional G-Quadruplex Aptamer Targeting Nucleolin and Topoisomerase 1: Antiproliferative Activity and Synergistic Effect of Conjugated Drugs.
Bioconjugate chemistry
(2022)
Jihoon Jo
,
Sangmin Bae
,
Jinseong Jeon
,
Hyungjun Youn
,
Gyeongjin Lee
,
Changill Ban
Bifunctional G-Quadruplex Aptamer Targeting Nucleolin and Topoisomerase 1: Antiproliferative Activity and Synergistic Effect of Conjugated Drugs.
Bioconjugate chemistry
34 (1) (2022)
Jihoon Jo
,
Sangmin Bae
,
Jinseong Jeon
,
Hyungjun Youn
,
Gyeongjin Lee
,
Changill Ban
Bifunctional G-Quadruplex Aptamer Targeting Nucleolin and Topoisomerase 1: Antiproliferative Activity and Synergistic Effect of Conjugated Drugs.
Bioconjugate chemistry
34 (1) (2022)
Jihoon Jo
,
Sangmin Bae
,
Jinseong Jeon
,
Hyungjun Youn
,
Gyeongjin Lee
,
Changill Ban
Bifunctional G-Quadruplex Aptamer Targeting Nucleolin and Topoisomerase 1: Antiproliferative Activity and Synergistic Effect of Conjugated Drugs.
Bioconjugate chemistry
34 (1) (2022)
Jihoon Jo
,
Sangmin Bae
,
Jinseong Jeon
,
Hyungjun Youn
,
Gyeongjin Lee
,
Changill Ban
Bifunctional G-Quadruplex Aptamer Targeting Nucleolin and Topoisomerase 1: Antiproliferative Activity and Synergistic Effect of Conjugated Drugs.
Bioconjugate chemistry
34 (1) (2022)